Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal (IgG2a) to Human B2M / Beta 2 Microglobulin
IHC, IHC - Paraffin, Western blot, Immunoprecipitation, Flow Cytometry, ELISA
Mouse Monoclonal [clone B2M-02] (IgG1) to Human B2M / Beta 2 Microglobulin
IHC, IHC - Paraffin, Western blot, Flow Cytometry, ELISA, Inhibition
Human B2M / Beta 2 Microglobulin
Human, Pig (tested or 100% immunogen sequence identity)
IgG1 Monoclonal [B2M-02]
Protein A purified
IHC - Paraffin (5 µg/ml)
Western blot (2 - 4 µg/ml)
Flow Cytometry (1 µg/ml)
Specificity and Use
Purified human B2M / Beta-2-Microglobulin.
Purified isolated human beta2-microglobulin
Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody,
PBS, 15 mM sodium azide, approx., pH 7.4.
Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles.
B2M / Beta 2 Microglobulin is a serum protein found in association with the major histocompatibility complex (MHC) class I heavy chain on the surface of nearly all nucleated cells. The protein has a predominantly beta-pleated sheet structure that can form amyloid fibrils in some pathological conditions. The encoded antimicrobial protein displays antibacterial activity in amniotic fluid. A mutation in this gene has been shown to result in hypercatabolic hypoproteinemia.